Farnesoid X Receptor Deficiency Induces Nonalcoholic Steatohepatitis in Low-Density Lipoprotein Receptor-Knockout Mice Fed a High-Fat Diet
- 1 January 2009
- journal article
- research article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 328 (1) , 116-122
- https://doi.org/10.1124/jpet.108.144600
Abstract
Nonalcoholic steatohepatitis (NASH) comprises dysregulation of lipid metabolism and inflammation. Identification of the various genetic and environmental susceptibility factors for NASH may provide novel treatments to limit inflammation and fibrosis in patients. This study utilized a mouse model of hypercholesterolemia, low-density lipoprotein receptor knockout (LDLr-/-) mice fed a high-fat diet for 5 months, to test the hypothesis that farnesoid X receptor (FXR) deficiency contributed to NASH development. Either the high-fat diet or FXR deficiency increased serum alanine aminotransferase activity, whereas only FXR deficiency increased bile acid and alkaline phosphatase levels. FXR deficiency and high-fat feeding increased serum cholesterol and triglycerides. Although high fat led to macrosteatosis and hepatocyte ballooning in livers of mice regardless of genotype, no inflammatory infiltrate was observed in the livers of LDLr-/- mice. In contrast, in the livers of LDLr-/-/FXR-/- mice, foci of inflammatory cells were observed occasionally when fed the control diet and were greatly increased when fed the high-fat diet. Consistent with enhanced inflammatory cells, hepatic levels of tumor necrosis factor α and intercellular adhesion molecule-1 mRNA were increased by the high-fat diet in LDLr-/-/FXR-/- mice. In agreement with elevated levels of procollagen 1α1 and TGF-β mRNA, type 1 collagen protein levels were increased in livers of LDLr-/-/FXR-/- mice fed a high-fat diet. In conclusion, FXR deficiency induces pathologic manifestations required for NASH diagnosis in a mouse model of hypercholesterolemia, including macrosteatosis, hepatocyte ballooning, and inflammation, which suggest a combination of FXR deficiency and high-fat diet is a risk factor for NASH development, and activation of FXR may be a therapeutic intervention in the treatment of NASH.This publication has 50 references indexed in Scilit:
- Expression and function of the bile acid receptor TGR5 in Kupffer cellsBiochemical and Biophysical Research Communications, 2008
- The pathogenesis of ethanol versus methionine and choline deficient diet-induced liver injuryBiochemical Pharmacology, 2008
- Independent Predictors of Steatohepatitis and Fibrosis in Asian Indian Patients with Non-Alcoholic SteatohepatitisDigestive Diseases and Sciences, 2007
- Prevalence of Nonalcoholic Fatty Liver Disease and Its Association With Cardiovascular Disease Among Type 2 Diabetic PatientsDiabetes Care, 2007
- Effects of FXR in foam-cell formation and atherosclerosis developmentBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2006
- Early diet-induced non-alcoholic steatohepatitis in APOE2 knock-in mice and its prevention by fibratesJournal of Hepatology, 2006
- Farnesoid X receptor is essential for normal glucose homeostasisJournal of Clinical Investigation, 2006
- Nonalcoholic Fatty Liver Disease: From Steatosis to CirrhosisHepatology, 2006
- Early Growth Response Factor-1 Is Critical for Cholestatic Liver InjuryToxicological Sciences, 2006
- Design and validation of a histological scoring system for nonalcoholic fatty liver disease†Hepatology, 2005